Clinical significance of aromatase protein expression in axillary node negative breast cancer

Journal of Cancer Research and Clinical Oncology

Volumn 133, Issue 6, 2007, Pages 401-409

  Lu, Jingsong ^a   Li, Hecheng ^a   Cao, Daocheng ^b   Di, Genhong ^a   Wu, Jiong ^a   Sheng, Kunwei ^a   Han, Qixia ^a   Shen, Zhenzhou ^a   Shao, Zhiming ^a  

^a FUDAN UNIVERSITY   (China)

^b Magang Hospital   (China)

Author keywords

Aromatase; Breast cancer; Matrix metalloproteinases; Prognosis

Indexed keywords

AROMATASE; ESTROGEN RECEPTOR; GELATINASE A; GELATINASE B; PROGESTERONE RECEPTOR;

ARTICLE; BREAST CARCINOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MEDICAL RESEARCH; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; PROTEIN EXPRESSION; SURVIVAL;

ADULT; AGED; AGED, 80 AND OVER; AROMATASE; BREAST NEOPLASMS; CARCINOMA; CARCINOMA, DUCTAL, BREAST; FEMALE; HUMANS; LYMPHATIC METASTASIS; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; PROGNOSIS; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; SURVIVAL ANALYSIS;

EID: 34248227263     PISSN: 01715216     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00432-006-0186-5     Document Type: Article

References (42)

1. Abbas Abidi SM, Howard EW, Dmytryk JJ, Pento JT (1997) Differential influence of antiestrogens on the in vitro release of gelatinases (type IV collagenases) by invasive and non-invasive breast cancer cells. Clin Exp Metastasis 15:432-439
2. Bolufer P, Ricart E, Lluch A, Vazquez C, Rodriguez A, Ruiz A, Llopis F, Garcia-Conde J, Romero R (1992) Aromatase activity and estradiol in human breast cancer: its relationship to estradiol and epidermal growth factor receptors and to tumor-node-metastasis staging. J Clin Oncol 10:438-446
3. Brodie A, Long B, Lu Q (1998) Aromatase expression in the human breast. Breast Cancer Res Treat 49(Suppl 1):S85-S91, discussion S109-S119
4. Brodie A, Lu Q, Long B (1999) Aromatase and its inhibitors. J Steroid Biochem Mol Biol 69:205-210
5. Brodie A, Lu Q, Nakamura J (1997) Aromatase in the normal breast and breast cancer. J Steroid Biochem Mol Biol 61:281-286
6. Brodie AH, Mouridsen HT (2003) Applicability of the intratumor aromatase preclinical model to predict clinical trial results with endocrine therapy. Am J Clin Oncol 26:S17-S26
7. Brodie AM, Lu Q, Long BJ, Fulton A, Chen T, Macpherson N, DeJong PC, Blankenstein MA, Nortier JW, Slee PH, van de Ven J, van Gorp JM, Elbers JR, Schipper ME, Blijham GH, Thijssen JH (2001) Aromatase and COX-2 expression in human breast cancers. J Steroid Biochem Mol Biol 79:41-47
8. Buzdar AU (2003) Advances in endocrine treatments for postmenopausal women with metastatic and early breast cancer. Oncologist 8:335-341
9. Dowsett M, Detre S, Rowlands M, Grimshaw R (1996) Oestrogen formation in breast: clinical and biological importance. J Endocrinol 150:S59-S63
10. Duffy MJ, Maguire TM, Hill A, McDermott E, O'Higgins N (2000) Metalloproteinases: role in breast carcinogenesis, invasion and metastasis. Breast Cancer Res 2:252-257
11. Ellis MJ, Hayes DF, Lippman ME (2004) Treatment of metastastatic breast cancer In: Harris Jr, Lippmen Me, Morrow M, Osborne Ck (eds) Disease of the breast. Lippincott Williams & Wilkins, Philadephia, pp 1101-1159
12. Elston CW, Ellis IO (2002) Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. C. W. Elston & I. O. Ellis. Histopathology 1991; 19:403-410. Histopathology 41:151
13. Eppenberger U, Levano S, Schoumacher F, Muller H, Eppenberger-Castori S (2001) Molecular epidemiology of aromatase expression in 1182 primary breast cancers. In: Miller W, Santen R (eds) Aromatase inhibition and breast cancer. Marcel Dekker, New York, pp 199-212
14. Esteban JM, Warsi Z, Haniu M, Hall P, Shively JE, Chen S (1992) Detection of intratumoral aromatase in breast carcinomas. An immunohistochemical study with clinicopathologic correlation. Am J Pathol 140:337-343
15. Evans TR, Rowlands MG, Silva MC, Law M, Coombes RC (1993) Prognostic significance of aromatase and estrone sulfatase enzymes in human breast cancer. J Steroid Biochem Mol Biol 44:583-587
16. Hankinson SE, Willett WC, Manson JE, Colditz GA, Hunter DJ, Spiegelman D, Barbieri RL, Speizer FE (1998) Plasma sex steroid hormone levels and risk of breast cancer in postmenopausal women. J Natl Cancer Inst 90:1292-1299
17. Hilsenbeck SG, Ravdin PM, de Moor CA, Chamness GC, Osborne CK, Clark GM (1998) Time-dependence of hazard ratios for prognostic factors in primary breast cancer. Breast Cancer Res Treat 52:227-237
18. Hirvonen R, Talvensaari-Mattila A, Paakko P, Turpeenniemi-Hujanen T (2003) Matrix metalloproteinase-2 (MMP-2) in T(1-2) no breast carcinoma. Breast Cancer Res Treat 77:85-91
19. Hsu SM, Raine L, Fanger H (1981) Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem 29:577-580
20. Iwata H, Kobayashi S, Iwase H, Masaoka A, Fujimoto N, Okada Y (1996) Production of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human breast carcinomas. Jpn J Cancer Res 87:602-611
21. Key TJ, Appleby PN, Reeves GK, Roddam A, Dorgan JF, Longcope C, Stanczyk FZ, Stephenson HE Jr, Falk RT, Miller R, Schatzkin A, Allen DS, Fentiman IS, Key TJ, Wang DY, Dowsett M, Thomas HV, Hankinson SE, Toniolo P, Akhmedkhanov A, Koenig K, Shore RE, Zeleniuch-Jacquotte A, Berrino F, Muti P, Micheli A, Krogh V, Sieri S, Pala V, Venturelli E, Secreto G, Barrett-Connor E, Laughlin GA, Kabuto M, Akiba S, Stevens RG, Neriishi K, Land CE, Cauley JA, Kuller LH, Cummings SR, Helzlsouer KJ, Alberg AJ, Bush TL, Comstock GW, Gordon GB, Miller SR, Longcope C (2003) Body mass index, serum sex hormones, and breast cancer risk in postmenopausal women. J Natl Cancer Inst 95:1218-1226
22. Kinoshita Y, Chen S (2003) Induction of aromatase (CYP19) expression in breast cancer cells through a nongenomic action of estrogen receptor alpha. Cancer Res 63:3546-3555
23. Kirma N, Gill K, Mandava U, Tekmal RR (2001) Overexpression of aromatase leads to hyperplasia and changes in the expression of genes involved in apoptosis, cell cycle, growth, and tumor suppressor functions in the mammary glands of transgenic mice. Cancer Res 61:1910-1918
24. Koyama H, Iwata H, Kuwabara Y, Iwase H, Kobayashi S, Fujii Y (2000) Gelatinolytic activity of matrix metalloproteinase-2 and-9 in oesophageal carcinoma; a study using in situ zymography. Eur J Cancer 36:2164-2170
25. Kute TE, Shao ZM, Sugg NK, Long RT, Russell GB, Case LD (1992) Cathepsin D as a prognostic indicator for node-negative breast cancer patients using both immunoassays and enzymatic assays. Cancer Res 52:5198-5203
26. Lu Q, Nakmura J, Savinov A, Yue W, Weisz J, Dabbs DJ, Wolz G, Brodie A (1996) Expression of aromatase protein and messenger ribonucleic acid in tumor epithelial cells and evidence of functional significance of locally produced estrogen in human breast cancers. Endocrinology 137:3061-3068
27. Mandava U, Kirma N, Tekmal RR (2001) Aromatase overexpression transgenic mice model: cell type specific expression and use of letrozole to abrogate mammary hyperplasia without affecting normal physiology. J Steroid Biochem Mol Biol 79:27-34
28. Missmer SA, Eliassen AH, Barbieri RL, Hankinson SE (2004) Endogenous estrogen, androgen, and progesterone concentrations and breast cancer risk among postmenopausal women. J Natl Cancer Inst 96:1856-1865
29. Mitropoulou TN, Tzanakakis GN, Kletsas D, Kalofonos HP, Karamanos NK (2003) Letrozole as a potent inhibitor of cell proliferation and expression of metalloproteinases (MMP-2 and MMP-9) by human epithelial breast cancer cells. Int J Cancer 104:155-160
30. Miyoshi Y, Ando A, Hasegawa S, Ishitobi M, Taguchi T, Tamaki Y, Noguchi S (2003) High expression of steroid sulfatase mRNA predicts poor prognosis in patients with estrogen receptor-positive breast cancer. Clin Cancer Res 9:2288-2293
31. Pacheco MM, Nishimoto IN, Mourao Neto M, Mantovani EB, Brentani MM (2001) Prognostic significance of the combined expression of matrix metalloproteinase-9, urokinase type plasminogen activator and its receptor in breast cancer as measured by Northern blot analysis. Int J Biol Markers 16:62-68
32. Pasqualini JR, Chetrite G, Blacker C, Feinstein MC, Delalonde L, Talbi M, Maloche C (1996) Concentrations of estrone, estradiol, and estrone sulfate and evaluation of sulfatase and aromatase activities in pre-and postmenopausal breast cancer patients. J Clin Endocrinol Metab 81:1460-1464
33. Pasqualini JR, Chetrite GS (2005) Recent insight on the control of enzymes involved in estrogen formation and transformation in human breast cancer. J Steroid Biochem Mol Biol 93:221-236
34. Sasano H, Suzuki T, Moriya T (2001) Immunohistochemistry of aromatase: a recent new development. In: Miller W, Santen R (eds) Aromatase inhibition and breast cancer. Marcel Dekker, New York, pp 191-198
35. Shenton KC, Dowsett M, Lu Q, Brodie A, Sasano H, Sacks NP, Rowlands MG (1998) Comparison of biochemical aromatase activity with aromatase immunohistochemistry in human breast carcinomas. Breast Cancer Res Treat 49(Suppl 1):S101-S107, discussion S109-S119
36. Silva MC, Rowlands MG, Dowsett M, Gusterson B, McKinna JA, Fryatt I, Coombes RC (1989) Intratumoral aromatase as a prognostic factor in human breast carcinoma. Cancer Res 49:2588-2591
37. Talvensaari-Mattila A, Paakko P, Hoyhtya M, Blanco-Sequeiros G, Turpeenniemi-Hujanen T (1998) Matrix metalloproteinase-2 immunoreactive protein: a marker of aggressiveness in breast carcinoma. Cancer 83:1153-1162
38. Tekmal RR, Ramachandra N, Gubba S, Durgam VR, Mantione J, Toda K, Shizuta Y, Dillehay DL (1996) Overexpression of int-5/aromatase in mammary glands of transgenic mice results in the induction of hyperplasia and nuclear abnormalities. Cancer Res 56:3180-3185
39. Turner KJ, Macpherson S, Millar MR, McNeilly AS, Williams K, Cranfield M, Groome NP, Sharpe RM, Fraser HM, Saunders PT (2002) Development and validation of a new monoclonal antibody to mammalian aromatase. J Endocrinol 172:21-30
40. van Landeghem AA, Poortman J, Nabuurs M, Thijssen JH (1985) Endogenous concentration and subcellular distribution of estrogens in normal and malignant human breast tissue. Cancer Res 45:2900-2906
41. Wolczynski S, Surazynski A, Swiatecka J, Palka J (2001) Estrogenic and antiestrogenic effects of raloxifene on collagen metabolism in breast cancer MCF-7 cells. Gynecol Endocrinol 15:225-233
42. Zhou C, Zhou D, Esteban J, Murai J, Siiteri PK, Wilczynski S, Chen S (1996) Aromatase gene expression and its exon I usage in human breast tumors. Detection of aromatase messenger RNA by reverse transcription-polymerase chain reaction. J Steroid Biochem Mol Biol 59:163-171